Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Keep up to date

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Methyldibromoglutaronitrile: Increased Incidence,but Lacks Clinical Relevance

Dermatitis®

Impact Factor: 3.4 / 5-Year Impact Factor: 3.7

Journal Homepage Submission guidelines

Restricted access

Research article

First published online December, 2021

Methyldibromoglutaronitrile: Increased Incidence,but Lacks Clinical Relevance

, , and

Volume 32, Issue 6

https://doi.org/10.1097/DER.0000000000000736

Abstract

Get full access to this article

View all access options for this article.

References

1.

Schalock

PC

, Dunnick

CA

, Nedorost

S

, et al.; American Contact Dermatitis Society Core Allergen Series Committee. American Contact Dermatitis Society Core Allergen Series: 2020 update. Dermatitis, 2020; 31(5):–.

2.

Scheman

A

, Patel

KR

, Roszko

K

, et al. Relative prevalence of contact allergens in North America in 2018. Dermatitis, 2020; 31(2):112–121.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains

Restricted access

i Drugs and i Devices Discovery Research: Preclinical Assays,Techniques,and Animal Model Studies for Ocular Hypotensives and Neuroprotectants

Restricted access

Eyes on New Product Development

Restricted access

The Effects of Commercially Available Preservative-Free FDA-Approved Triamcinolone (Triesence ® ) on Retinal Cells in Culture